As SCOTUS considers renewed challenges to affirmative action, Assoc. Dean Donald Harris and Prof. Zamir Ben-Dan join Prof. Timothy Welbeck of the Center for Anti-racism Research in a look at its past and possible futures. Read More

The Supreme Court appears poised to gut affirmative action. Assoc. Dean Donald Harris and Prof. Zamir Ben-Dan discuss the policy’s history, why it remains important, and what will likely happen without it in this explainer for Capital B. Read More

Legislators comparing a restrictive North Carolina abortion bill to European policies are ignoring important context, says Beck Chair Patty Skuster, like public health care, social services, parental leave, and child care. Read More

Assoc. Dean Donald Harris offers his analysis of Warhol v. Goldsmith in this Bloomberg Law op-ed. Read More

Litigation between judges on the Federal Circuit bench not only raises significant issues, it threatens to leave “wounds” that will “take a long time to heal, if they ever do,” says Prof. Paul Gugliuzza. Read More

With all eyes on a Texas order limiting FDA authority over abortion pills, Dean Rebouche discusses two cases making the opposite claim – that FDA regulations preempt conflicting state laws. Read More

Prof. Jules Epstein joins criticism of an evidentiary standard that requires judges to evaluate scientific testimony: “A courtroom is a really lousy place to decide science.” Read More

Dean Rebouche says no court has ruled on the scope of the Comstock Act, a pillar of anti-abortion strategy, likely sending abortion “right back to the Supreme Court.” Read More

Dean Rebouche pushes back against the “widespread conflation of discretion and defiance” regarding the FDA’s enforcement discretion should its approval of mifepristone be rolled back. Read More

A new generation of anti-abortion activists is not afraid to lose short-term battles in pursuit of their long-term goal: eliminating abortion from the country, says Dean Rachel Rebouche. Read More